BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7397200)

  • 1. Responses of hepatic phosphoenolypyruvate carboxykinase activities from normal and diabetic rats to quinolinate inhibition and ferrous ion activation.
    Maxwell JR; Ray PD
    Biochim Biophys Acta; 1980 Jul; 614(1):163-72. PubMed ID: 7397200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of phosphoenolpyruvate carboxykinase, glyceroneogenesis and fatty acid synthesis in rat adipose tissue by quinolinate and 3-mercaptopicolinate.
    MacDonald MJ; Grewe BK
    Biochim Biophys Acta; 1981 Jan; 663(1):302-13. PubMed ID: 7213768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Fe2+ and Mn2+ on 3-mercaptopicolinate inhibition of cytosolic and mitochondrial phosphoenolpyruvate carboxykinase of five species.
    MacDonald MJ
    Biochim Biophys Acta; 1978 Sep; 526(1):293-8. PubMed ID: 687651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative inhibition of mitochondrial and cytosolic phosphoenolpyruvate carboxykinases by stereospecific substrate analogues.
    Duffy TH; Markovitz PJ; Chuang DT; Utter MF; Nowak T
    Proc Natl Acad Sci U S A; 1981 Nov; 78(11):6680-3. PubMed ID: 6947246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytosolic and mitochondrial phosphoenolpyruvate carboxykinase of the bullfrog, Rana catesbeiana, liver.
    Goto Y; Ohki Y; Shimizu J; Shukuya R
    Biochim Biophys Acta; 1981 Feb; 657(2):383-9. PubMed ID: 6971127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation and inactivation of phosphoenolpyruvate carboxykinase by ferrous ions.
    Reynolds CH
    Biochem J; 1980 Feb; 185(2):451-4. PubMed ID: 7396825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolinate inhibition of gluconeogenesis is dependent on cytosolic oxalacetate concentration. An explanation for the differential inhibition of lactate and pyruvate gluconeogenesis.
    Gabbay RA
    FEBS Lett; 1985 Sep; 189(2):367-72. PubMed ID: 2931305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the cytosol and mitochondrial pathways to phosphoenolpyruvate formation during gluconeogenesis.
    Peng YS; Brooks M; Elson C; Shrago E
    J Nutr; 1973 Oct; 103(10):1489-95. PubMed ID: 4745523
    [No Abstract]   [Full Text] [Related]  

  • 9. 3-Mercaptopicolinic acid, a preferential inhibitor of the cytosolic phosphoenolpyruvate carboxykinase.
    Robinson BH; Oei J
    FEBS Lett; 1975 Oct; 58(1):12-5. PubMed ID: 1225570
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of inhibition by L-tryptophan or quinolinate of gluconeogenesis in diabetic rats.
    Alvares FL; Ray PD
    J Biol Chem; 1974 Apr; 249(7):2058-62. PubMed ID: 4274233
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors affecting the manganese and iron activation of the phosphoenolpyruvate carboxykinase isozymes from rabbit.
    Lambeth DO; Muhonen WW; Jacoby GH; Ray PD
    Biochim Biophys Acta; 1992 Dec; 1156(1):85-91. PubMed ID: 1472544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gluconeogenesis in rat renal cortex slices by metabolites of L-tryptophan in vitro.
    Endou H; Reuter E; Weber HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(3):297-308. PubMed ID: 1153021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoenolpyruvate carboxykinase in mouse pancreatic islets. ATP-induced changes in sensitivity to Mn2+ activation.
    Hedeskov CJ; Capito K; Thams P
    Biochim Biophys Acta; 1984 Nov; 791(1):37-44. PubMed ID: 6388641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protein factor required for activation of phosphoenolpyruvate carboxykinase by ferrous ions.
    Bentle LA; Snoke RE; Lardy HA
    J Biol Chem; 1976 May; 251(10):2922-8. PubMed ID: 1270434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoenolpyruvate carboxykinase from Onchocerca volvulus and O. gibsoni.
    Walter RD; Albiez EJ
    Trop Med Parasitol; 1986 Dec; 37(4):356-8. PubMed ID: 2951841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian and avian liver phosphoenolpyruvate carboxykinase. Alternate substrates and inhibition by analogues of oxaloacetate.
    Ash DE; Emig FA; Chowdhury SA; Satoh Y; Schramm VL
    J Biol Chem; 1990 May; 265(13):7377-84. PubMed ID: 2332432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+-mediated activation of phosphoenolpyruvate carboxykinase occurs via release of Fe2+ from rat liver mitochondria.
    Merryfield ML; Lardy HA
    J Biol Chem; 1982 Apr; 257(7):3628-35. PubMed ID: 6174522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tryptophan and its metabolites on gluconeogenesis in mammalian tissues.
    Pogson CI; Crisp DM; Smith SA
    Acta Vitaminol Enzymol; 1975; 29(1-6):232-5. PubMed ID: 1244097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasciola hepatica: inhibition of phosphoenolpyruvate carboxykinase, and end-product formation by quinolinic acid and 3-mercaptopicolinic acid.
    Lloyd GM; Barrett J
    Exp Parasitol; 1983 Oct; 56(2):259-65. PubMed ID: 6225676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoenolpyruvate carboxykinase ferroactivator 1. Mechanism of action and identity with glutathione peroxidase.
    Punekar NS; Lardy HA
    J Biol Chem; 1987 May; 262(14):6714-9. PubMed ID: 3571281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.